Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikola Sprigg

Showing results (91-100 of 189) with videos related to

Pageof 19
Sort By:
BMJ Open|February 13, 2018
Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trialRob A Dineen, Stefan Pszczolkowski, Katie Flaherty, et al.
The Lancet. Neurology|April 18, 2017
Increasing value and reducing waste in stroke researchEivind Berge, Rustam Al-Shahi Salman, H Bart van der Worp, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 12, 2020
Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2)Keith W Muir, Diederik Bulters, Mark Willmot, et al.
Clinical Medicine (London, England)|December 12, 2022
Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physicianKailash Krishnan, Zhe Kang Law, Jatinder S Minhas, et al.
European Stroke Journal|October 19, 2020
Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel diseaseJoanna Wardlaw, Philip M W Bath, Fergus Doubal, et al.
European Stroke Journal|January 28, 2020
Women in the European Stroke Organisation: One, two, many… - A <i>Top Down</i> and <i>Bottom Up</i> approachElse Charlotte Sandset, Diana Aguiar de Sousa, Hanne Christensen, et al.
Neurology|September 4, 2025
Safety and Efficacy of Perispinal Etanercept for Chronic Stroke: A Randomized Clinical TrialVincent N Thijs, Geoffrey C Cloud, Nigel Gilchrist, et al.
Contemporary Clinical Trials Communications|December 12, 2018
Central masked adjudication of stroke diagnosis at trial entry offered no advantage over diagnosis by local clinicians: Secondary analysis and simulationPeter J Godolphin, Trish Hepburn, Nikola Sprigg, et al.
European Stroke Journal|July 30, 2024
Outcome 1 year after ICH: Data from the Tranexamic acid for IntraCerebral Haemorrhage 2 (TICH-2) trialZhe Kang Law, Chaamanti Sivakumar Menon, Lisa J Woodhouse, et al.
Trials|November 8, 2015
Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST)Polly Scutt, Dan Blackburn, Kailash Krishnan, et al.
Pageof 19

Showing results (91-100 of 189) with videos related to

Sort By:
Pageof 19
BMJ Open|February 13, 2018
Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trialRob A Dineen, Stefan Pszczolkowski, Katie Flaherty, et al.
The Lancet. Neurology|April 18, 2017
Increasing value and reducing waste in stroke researchEivind Berge, Rustam Al-Shahi Salman, H Bart van der Worp, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 12, 2020
Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2)Keith W Muir, Diederik Bulters, Mark Willmot, et al.
Clinical Medicine (London, England)|December 12, 2022
Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physicianKailash Krishnan, Zhe Kang Law, Jatinder S Minhas, et al.
European Stroke Journal|October 19, 2020
Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel diseaseJoanna Wardlaw, Philip M W Bath, Fergus Doubal, et al.
European Stroke Journal|January 28, 2020
Women in the European Stroke Organisation: One, two, many… - A <i>Top Down</i> and <i>Bottom Up</i> approachElse Charlotte Sandset, Diana Aguiar de Sousa, Hanne Christensen, et al.
Neurology|September 4, 2025
Safety and Efficacy of Perispinal Etanercept for Chronic Stroke: A Randomized Clinical TrialVincent N Thijs, Geoffrey C Cloud, Nigel Gilchrist, et al.
Contemporary Clinical Trials Communications|December 12, 2018
Central masked adjudication of stroke diagnosis at trial entry offered no advantage over diagnosis by local clinicians: Secondary analysis and simulationPeter J Godolphin, Trish Hepburn, Nikola Sprigg, et al.
European Stroke Journal|July 30, 2024
Outcome 1 year after ICH: Data from the Tranexamic acid for IntraCerebral Haemorrhage 2 (TICH-2) trialZhe Kang Law, Chaamanti Sivakumar Menon, Lisa J Woodhouse, et al.
Trials|November 8, 2015
Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST)Polly Scutt, Dan Blackburn, Kailash Krishnan, et al.
Pageof 19